Your browser doesn't support javascript.
loading
Insulin-Degrading Enzyme Is a Non Proteasomal Target of Carfilzomib and Affects the 20S Proteasome Inhibition by the Drug.
Tundo, Grazia Raffaella; Sbardella, Diego; Oddone, Francesco; Grasso, Giuseppe; Marini, Stefano; Atzori, Maria Grazia; Santoro, Anna Maria; Milardi, Danilo; Bellia, Francesco; Macari, Gabriele; Graziani, Grazia; Polticelli, Fabio; Cascio, Paolo; Parravano, Mariacristina; Coletta, Massimo.
Afiliação
  • Tundo GR; IRCCS-Fondazione BIETTI, 00198 Rome, Italy.
  • Sbardella D; IRCCS-Fondazione BIETTI, 00198 Rome, Italy.
  • Oddone F; IRCCS-Fondazione BIETTI, 00198 Rome, Italy.
  • Grasso G; Department of Chemical Science, University of Catania, 95125 Catania, Italy.
  • Marini S; Department of Clinical Sciences and Translational Medicine, University of Roma Tor Vergata, 00133 Rome, Italy.
  • Atzori MG; Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
  • Santoro AM; Institute of Crystallography, CNR, 95126 Catania, Italy.
  • Milardi D; Institute of Crystallography, CNR, 95126 Catania, Italy.
  • Bellia F; Institute of Crystallography, CNR, 95126 Catania, Italy.
  • Macari G; Department of Sciences, Rome Tre University, 00146 Rome, Italy.
  • Graziani G; Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
  • Polticelli F; Department of Sciences, Rome Tre University, 00146 Rome, Italy.
  • Cascio P; National Institute of Nuclear Physics, Rome Tre Section, 00146 Rome, Italy.
  • Parravano M; Department of Veterinary Sciences, University of Turin, 10095 Grugliasco, Italy.
  • Coletta M; IRCCS-Fondazione BIETTI, 00198 Rome, Italy.
Biomolecules ; 12(2)2022 02 16.
Article em En | MEDLINE | ID: mdl-35204815

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Insulisina / Mieloma Múltiplo / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Insulisina / Mieloma Múltiplo / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article